US4359476A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Adjacently substituted cycloalkane-amide analgesics
Assignee: Pharmacia and Upjohn Co
•
Filing: 1981-04-09
•
Granted: 1982-11-16
•
Expires: 2001-04-09
Abstract
Abstract N-[2-Amino(oxy or thio group) substituted-cycloaliphatic]phenylacetamide and -benzamide compounds, having the oxy- or thio group substituents on a cycloaliphatic ring carbon adjacent to either of the nitrogen bearing carbons of the cycloaliphatic ring, e.g., cis- and trans-4-bromo-N-[3-methoxy-2-(1-pyrrolidinyl)cyclohexyl]-N-methylbenzamide, and trans-3,4-dichloro-N-methyl-N-[7-(1-pyrridolinyl)-1,4-dioxaspiro[4.5]dec-6-yl]benzeneacetamide, and salts thereof, have useful analgesic activity and low abuse liability in humans and valuable warm blooded animals. Processes for their production and pharmaceutical compositions and method of use are also disclosed.
Inventors
- 👤 Lester J. Kaplan
- 👤 Moses W. McMillan
- 👤 Jacob Szmuszkovicz
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 21:33
CPC Classifications
C; C07; C07D; C07D295/00; C07D295/04; C07D295/12; C07D295/135; A; A61; A61P; A61P25/00; A61P25/04; C07D317/00; C07D317/08; C07D317/72; C07D327/00; C07D327/02; C07D327/06; C07D491/00; C07D491/02; C07D491/10; C07D493/00; C07D493/02; C07D493/10; C07F; C07F7/00; C07F7/02; C07F7/08; C07F7/18; C07F7/1804
Claims Analysis
Total Claims: 22
Claim 1
Independent Claim
358 words
A compound of the formula wherein: R is hydrogen or C 1 to C 3 -alkyl; R 1 and R 2 , taken separately, are each hydrogen or C 1 to C 3 -alkyl; R 1 and R 2 , taken together with the nitrogen to which they are bonded, are azetidinyl, pyrrolidinyl or piperidinyl; R 3 , taken separately, is hydroxy, C 1 to C 2 -alkyloxy, or C 1 to C 3 -alkanoyloxy; R 4 , taken separately, is hydrogen when R 3 is hydroxy, C 1 to C 2 -alkyloxy,or C 1 to C 3 -alkanoyloxy; R 3 and R 4 , taken together, complete a moiety selected from the group, ═G (oxo or thioxo), --G--CH 2 CH 2 --G--, --G--CH 2 CH 2 CH 2 --G--, --G--CH 2 CH(CH 3 )CH 2 --G--, --G--CH 2 C(CH 3 ) 2 CH 2 --G--, wherein both G moieties in the same group are oxygen or bivalent sulfur, ═N˜OH, and ═N˜OC(═O)CH 3 , wherein each G is oxygen or bivalent sulfur; X and Y are independently selected from the group consisting of hydrogen, a halogen having an atomic number from 9 to 35, trifluoromethyl, nitro, methoxy, hydroxy, azido, C 1 to C 3 -alkyl, phenyl, methanesulfonyl, cyano, amino, C 1 to C 3 -alkoxycarbonyl, C 1 to C 3 -alkanoyloxy, C 1 to C 3 -carboxacylamino(--NHC(═O)R 6 , wherein R 6 is hydrogen or C 1 to C 2 -alkyl); p and n are whole number integers selected from the group zero, 2, 3, or 4 such that one of p and n is zero and the other of p and n is 2, 3, or 4; q is zero or 1; E is oxygen or bivalent sulfur; provided that when R is C 1 to C 3 -alkyl, R 1 and R 2 taken together with the nitrogen to which they are bonded complete a pyrrolidinyl ring, p is 3 and n is 0, q is 1, X and Y are chlorine in the 3 and 4 positions, R 3 is not hydroxy, C 1 to C 2 -alkoxy or C 1 to C 3 -alkanoyloxy;
Claim 2
Dependent Claim
358 words
A compound of the formula wherein: R is hydrogen or C 1 to C 3 -alkyl; R 1 and R 2 , taken separately, are each hydrogen or C 1 to C 3 -alkyl; R 1 and R 2 , taken together with the nitrogen to which they are bonded, are azetidinyl, pyrrolidinyl or piperidinyl; R 3 , taken separately, is hydroxy, C 1 to C 2 -alkyloxy, or C 1 to C 3 -alkanoyloxy; R 4 , taken separately, is hydrogen when R 3 is hydroxy, C 1 to C 2 -alkyloxy,or C 1 to C 3 -alkanoyloxy; R 3 and R 4 , taken together, complete a moiety selected from the group, ═G (oxo or thioxo), --G--CH 2 CH 2 --G--, --G--CH 2 CH 2 CH 2 --G--, --G--CH 2 CH(CH 3 )CH 2 --G--, --G--CH 2 C(CH 3 ) 2 CH 2 --G--, wherein both G moieties in the same group are oxygen or bivalent sulfur, ═N˜OH, and ═N˜OC(═O)CH 3 , wherein each G is oxygen or bivalent sulfur; X and Y are independently selected from the group consisting of hydrogen, a halogen having an atomic number from 9 to 35, trifluoromethyl, nitro, methoxy, hydroxy, azido, C 1 to C 3 -alkyl, phenyl, methanesulfonyl, cyano, amino, C 1 to C 3 -alkoxycarbonyl, C 1 to C 3 -alkanoyloxy, C 1 to C 3 -carboxacylamino(--NHC(═O)R 6 , wherein R 6 is hydrogen or C 1 to C 2 -alkyl); p and n are whole number integers selected from the group zero, 2, 3, or 4 such that one of p and n is zero and the other of p and n is 2, 3, or 4; q is zero or 1; E is oxygen or bivalent sulfur; provided that when R is C 1 to C 3 -alkyl, R 1 and R 2 taken together with the nitrogen to which they are bonded complete a pyrrolidinyl ring, p is 3 and n is 0, q is 1, X and Y are chlorine in the 3 and 4 positions, R 3 is not hydroxy, C 1 to C 2 -alkoxy or C 1 to C 3 -alkanoyloxy;
Claim 3
Dependent Claim
72 words
A compound according to claim 1, wherein R is C 1 to C 3 -alkyl; R 1 and R 2 are taken together with the nitrogen to which they are bonded to complete an N-pyrrolidinyl ring; R 3 is methoxy; R 4 is hydrogen; X is hydrogen; Y is a halogen having an atomic number of from 9 to 35; p is 3; n is 0; q is 0; E is oxygen;
Claim 4
Dependent Claim
11 words
A compound according to claim 2, wherein the compound is (1α,2β,3β)-4-bromo-N-[3-methoxy-2-(1-pyrrolidinyl)cyclohex
Claim 5
Dependent Claim
11 words
A compound according to claim 2, wherein the compound is (1α,2β,3α)-4-bromo-N-[3-methoxy-2-(1-pyrrolidinyl)cyclohe
Claim 6
Dependent Claim
77 words
A compound according to claim 1, wherein R is C 1 to C 3 -alkyl; R 1 and R 2 are taken together with the nitrogen to which they are bonded to complete an N-pyrrolidinyl ring; R 3 and R 4 are taken together to complete an ethylenedioxy ketal ring; X and Y are each halogen having an atomic number of from 9 to 35; p is zero; n is 3; q is 1; E is oxygen;
Claim 7
Dependent Claim
11 words
A compound according to claim 5, wherein the compound is trans-3,4-dichloro-N-methyl-N-[7-(1-pyrrolidinyl)-1,4-dioxaspiro[4.5]dec-6-yl]benzeneacetamide,
Claim 8
Dependent Claim
70 words
A compound according to claim 1, wherein R is C 1 to C 3 -alkyl; R 1 and R 2 are each C 1 to C 3 -alkyl; R 3 and R 4 are taken together to complete an ethylenedioxy ketal group; X is hydrogen; Y is a halogen having an atomic number of from 9 to 35; p is 0; n is 3; q is 0; E is oxygen;
Claim 9
Dependent Claim
11 words
A compound according to claim 7, wherein the compound is trans-4-bromo-N-[7-(dimethylamino)-1,4-dioxaspiro[4.5]dec-6-yl]-N-methylbenzamide,
Claim 10
Dependent Claim
70 words
A compound according to claim 7, wherein R is C 1 to C 3 -alkyl; R 1 and R 2 are each C 1 to C 3 -alkyl; R 3 and R 4 are taken together to denote an ethylenedioxy ketal group; X and Y are each halogen atoms having an atomic number of from 9 to 35; p is 0; n is 3; q is 1; E is oxygen;
Claim 11
Dependent Claim
11 words
A compound according to claim 9, wherein the compound is trans-3,4-dichloro-N-[7-(dimethylamino)-1,4-dioxaspiro[4.5]dec-6-yl]-N-methylbenzeneacetamide,
Claim 12
Dependent Claim
80 words
A compound according to claim 1, wherein R is C 1 to C 3 -alkyl; R 1 and R 2 are taken together with the nitrogen to which they are attached to complete an N-pyrrolidinyl ring; R 3 and R 4 are taken together to complete an ethylenedioxy ring; X is a halogen having an atomic number of from 9 to 35 on the 4-position; Y is hydrogen; p is 3; n is 0; q is 0; E is oxygen;
Claim 13
Dependent Claim
11 words
A compound according to claim 11, wherein the compound is 4-bromo-N-methyl-N-[6-(1-pyrrolidinyl)-1,4-dioxaspiro[4.5]dec-7-yl]benzamide;
Claim 14
Dependent Claim
80 words
A compound according to claim 1, wherein R is C 1 to C 3 -alkyl; R 1 and R 2 are taken together with the nitrogen to which they are bonded to complete an N-pyrrolidinyl ring; R 3 and R 4 are taken together to denote an oxo function; X is a halogen having an atomic number of from 9 to 35 in the 4-position; Y is hydrogen; p is 3; n is 0; q is 0; E is oxygen;
Claim 15
Dependent Claim
11 words
A compound according to claim 13, wherein the compound is 4-bromo-N-methyl-N-[3-oxo-2-(1-pyrrolidinyl)cyclohexyl]benzamide,
Claim 16
Dependent Claim
19 words
A compound according to claim 1 wherein the compound is selected from the group consisting of 4-bromo-N-[3-hydroxy-2-(1-pyrrolidinyl)cyclohexyl]-N-methylbenzamide, 4-bromo-N-methyl-N-[7-(1-pyrrolidinyl)-1,4-dioxaspiro[4.5]dec-6-yl]benzamide, 4-bromo-N-[2-hydroxy-6-(1-pyrrolidinyl)cyclohexyl]-N-methylbenzamide,
Claim 17
Dependent Claim
21 words
A composition useful in pharmaceutically effective dosage unit form for alleviating pain in warm blooded mammals which comprises a compound of
Claim 18
Dependent Claim
21 words
A composition useful in pharmaceutically effective dosage unit form for alleviating pain in warm blooded mammals which comprises a compound of
Claim 19
Dependent Claim
95 words
A composition of claim 16 wherein the compound of claim 1 is a compound of the formula ##STR2## wherein R is C 1 to C 3 -alkyl; R 1 and R 2 are taken together with the nitrogen to which they are bonded to complete an N-pyrrolidinyl ring; R 3 and R 4 are taken together to complete an ethylenedioxy ketal ring; X and Y are each halogen having an atomic number of from 9 to 35; p is zero; n is 3; q is 1; E is oxygen; or a pharmaceutically acceptable salt thereof.
Claim 20
Dependent Claim
19 words
A composition of claim 17 wherein the compound of claim 1 is trans-3,4-dichloro-N-methyl-N-[7-(1-pyrrolidinyl)-1,4-dioxaspiro[4.5]dec-6-yl]benzeneacetamide, or a pharmaceutically acceptable salt thereof.
Claim 21
Dependent Claim
28 words
A method for alleviating pain which comprises administering to an animal suffering pain an effective amount of a compound of claim 1 in a pharmaceutical dosage unit form.
Claim 22
Dependent Claim
19 words
A method of claim 19 wherein the compound of claim 1 is trans-3,4-dichloro-N-methyl-N-[7-(1-pyrrolidinyl)-1,4-dioxaspiro[4.5]dec-6-yl]benzeneacetamide, or a pharmaceutically acceptable salt thereof.
References Cited (Backward Citations)
US3510492A
Cited
US4065573A
Cited
US4098904A
Cited
US4145435A
Cited
US4156733A
Cited
US4212878A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-11-15 | 1986-05-17 | 1986-11-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-11-15 | 1990-05-17 | 1990-11-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-11-15 | 1994-05-17 | 1994-11-16 | $7700.00 | Window Closed / Lapsed |